Levy-Lahad E - Search Results

1

High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.

Beller U, Halle D, Catane R, Kaufman B, Hornreich G, Levy-Lahad E. Beller U, et al. Gynecol Oncol. 1997 Nov;67(2):123-6. doi: 10.1006/gyno.1997.4844. Gynecol Oncol. 1997. PMID: 9367693

2

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D. Levy-Lahad E, et al. Am J Hum Genet. 1997 May;60(5):1059-67. Am J Hum Genet. 1997. PMID: 9150153 Free PMC article.

3

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

Hornreich G, Beller U, Lavie O, Renbaum P, Cohen Y, Levy-Lahad E. Hornreich G, et al. Gynecol Oncol. 1999 Nov;75(2):300-4. doi: 10.1006/gyno.1999.5568. Gynecol Oncol. 1999. PMID: 10525392 Review.

4

BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.

Levy-Lahad E, Krieger M, Gottfeld O, Renbaum P, Klein G, Eisenberg S, Lahad A, Kaufman B, Catane R. Levy-Lahad E, et al. J Cell Biochem Suppl. 2000;34:13-8. J Cell Biochem Suppl. 2000. PMID: 10762009 Review.

5

BRCA1 germline mutations in women with uterine serous papillary carcinoma.

Lavie O, Hornreich G, Ben Arie A, Renbaum P, Levy-Lahad E, Beller U. Lavie O, et al. Obstet Gynecol. 2000 Jul;96(1):28-32. doi: 10.1016/s0029-7844(00)00851-6. Obstet Gynecol. 2000. PMID: 10862837

6

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.

Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, Gershoni-Baruch R. Levy-Lahad E, et al. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3232-6. doi: 10.1073/pnas.051624098. Proc Natl Acad Sci U S A. 2001. PMID: 11248061 Free PMC article.

7

Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.

Wolf I, Laitman Y, Rubinek T, Abramovitz L, Novikov I, Beeri R, Kuro-O M, Koeffler HP, Catane R, Freedman LS, Levy-Lahad E, Karlan BY, Friedman E, Kaufman B. Wolf I, et al. Oncogene. 2010 Jan 7;29(1):26-33. doi: 10.1038/onc.2009.301. Epub 2009 Oct 5. Oncogene. 2010. PMID: 19802015

8

Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.

Friedman E, Bar-Sade Bruchim R, Kruglikova A, Risel S, Levy-Lahad E, Halle D, Bar-On E, Gershoni-Baruch R, Dagan E, Kepten I, Peretz T, Lerer I, Wienberg N, Shushan A, Abeliovich AD. Friedman E, et al. Am J Hum Genet. 1998 Oct;63(4):1224-7. doi: 10.1086/302040. Am J Hum Genet. 1998. PMID: 9758598 Free PMC article. No abstract available.

9

A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.

Yakobson E, Eisenberg S, Isacson R, Halle D, Levy-Lahad E, Catane R, Safro M, Sobolev V, Huot T, Peters G, Ruiz A, Malvehy J, Puig S, Chompret A, Avril MF, Shafir R, Peretz H, Bressac-de Paillerets B. Yakobson E, et al. Eur J Hum Genet. 2003 Apr;11(4):288-96. doi: 10.1038/sj.ejhg.5200961. Eur J Hum Genet. 2003. PMID: 12700603

10

Cancer risks among BRCA1 and BRCA2 mutation carriers.

Levy-Lahad E, Friedman E. Levy-Lahad E, et al. Br J Cancer. 2007 Jan 15;96(1):11-5. doi: 10.1038/sj.bjc.6603535. Br J Cancer. 2007. PMID: 17213823 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters